![]() |
|||
|
|
|
|
| UPDATE: May 2009 | MW: 356.40 | MF: C16H17N2O4S•Na |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 1,500 mg/kg (6-11 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
ANTBAL 18,815,1973
|
subcutaneous | mouse
lowest published toxic dose: 30 mg/kg (14 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
CRSBAW 158,528,1964
|
subcutaneous | rat
lowest published toxic dose: 1,500 mg/kg (1-5 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
ANTBAL 18,815,1973
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
subcutaneous | rat
lowest published toxic dose: 1,840 mg/kg/46 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Blood: Lymphoma including Hodgkin's disease Tumorigenic: Tumors at site of application
BJCAAI 15,85,1961
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intracerebral | mouse
lethal dose (50 percent kill): 3,800 µg/kg
|
Behavioral: Convulsions or effect on seizure threshold
|
NYKZAU 55,23,1959
|
intramuscular | cat
lowest published toxic dose: 400,000 units/kg
|
Behavioral: Convulsions or effect on seizure threshold
|
FATOAO 49,22,1986
|
intramuscular | cat
lowest published toxic dose: 500,000 units/kg
|
Brain and Coverings: Changes in surface EEG | Behavioral: Convulsions or effect on seizure threshold
FATOAO 50,33,1987
|
intramuscular | guinea pig
lowest published lethal dose: 60 mg/kg
|
N/R
|
LBASAE 30,524,1980
|
intramuscular | mouse
lethal dose (50 percent kill): 2,800 mg/kg
|
N/R
|
ARZNAD 9,31,1959
|
intraperitoneal | mouse
lethal dose (50 percent kill): 3,314 mg/kg
|
N/R
|
ABANAE 3,540,1955/1956
|
intravenous | guinea pig
lowest published lethal dose: 150 mg/kg
|
Gastrointestinal: Other changes | Nutritional and Gross Metabolic: Other changes
ARZNAD 9,31,1959
|
intravenous | mouse
lethal dose (50 percent kill): 1,500 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Behavioral: Change in motor activity (specific assay) Lung, Thorax, or Respiration: Other changes
ARZNAD 9,31,1959
|
intravenous | mouse
lethal dose (50 percent kill): 3,090 mg/kg
|
N/R
|
VCVPS* -,373,1998
|
intravenous | rat
lethal dose (50 percent kill): 3,020 mg/kg
|
Cardiac: Other changes | Lung, Thorax, or Respiration: Respiratory depression
ARZNAD 9,31,1959
|
oral | guinea pig
lowest published lethal dose: 30 mg/kg
|
Behavioral: Food intake (animal) | Gastrointestinal: Hypermotility, diarrhea
VCVPS* -,373,1998
|
oral | mouse
lethal dose (50 percent kill): >4 gm/kg
|
N/R
|
ABANAE 3,540,1955/1956
|
oral | rat
lethal dose (50 percent kill): 6,916 mg/kg
|
Behavioral: Tremor | Behavioral: Convulsions or effect on seizure threshold Gastrointestinal: Other changes
AMPMAR 39,259,1978
|
parenteral | rat
lethal dose (50 percent kill): 2,900 µg/kg
|
N/R
|
AACHAX -,863,1965
|
subcutaneous | mouse
lethal dose (50 percent kill): 4,750 mg/kg
|
N/R
|
NYKZAU 55,23,1959
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
HUTOX* -,429,1996
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X4380 |
Number of Industries 1; Total Number of Facilities 137; Number of Occupations 5; Total Number of Employees Exposed 7,315; Total Number of Female Employees Exposed 5,985 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
AACHAX
|
Antimicrobial Agents and Chemotherapy (1961-70). (Ann Arbor, MI) 1961-70. For publisher
information, see AMACCQ.
|
ABANAE
|
Antibiotics Annual. (New York, NY) 1953-60. For publisher information, see AMACCQ.
|
AMPMAR
|
Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF,
B.P.22, F-41353 Vineuil, France) V.7- 1946-
|
ANTBAL
|
Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH.
|
ARZNAD
|
Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960
Aulendorf, Fed. Rep. Ger.) V.1- 1951-
|
BJCAAI
|
British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS,
UK) V.1- 1947-
|
CRSBAW
|
Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22,
F-41353 Vineuil, France) V.1- 1849-
|
FATOAO
|
Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939-
|
HUTOX*
|
|
LBASAE
|
Laboratory Animal Science. (American Assoc. for Laboratory Animal Science, 210 N. Hammes
Ave., Suite 205, Joliet, IL 60435) V.21- 1971-
|
NYKZAU
|
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto
Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40-
1944-
|
VCVPS*
|
"Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances.
Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998.
|
| |